Skip to main content

Table 5 Primary medical condition reported by 61,379 patients seeking medical cannabis certification, by gender

From: Medical cannabis use in the United States: a retrospective database study

Primary Condition Patients, n (%) Male, n (%) Female, n (%)
n = 61,379 n = 33,651 n = 23,209
Unspecified Chronic Pain 23,817 (38.8%) 14,164 (42.1%) 8710 (37.5%)
Anxiety 8280 (13.5%) 3949 (11.7%) 3224 (13.9%)
Post Traumatic Stress Disorder 5143 (8.4%) 2874 (8.5%) 1982 (8.5%)
Back & Neck Problems 3969 (6.5%) 2506 (7.4%) 1125 (4.8%)
Arthritis 2395 (3.9%) 1149 (3.4%) 1048 (4.5%)
Insomnia 2096 (3.4%) 1187 (3.5%) 673 (2.9%)
Cancer Related Pain 1641 (2.7%) 782 (2.3%) 722 (3.1%)
Depression 1249 (2.0%) 575 (1.7%) 470 (2.0%)
Migraines 1245 (2.0%) 499 (1.5%) 656 (2.8%)
Muscle Spasms 1038 (1.7%) 624 (1.9%) 384 (1.7%)
ADD/ADHD 1002 (1.6%) 624 (1.9%) 235 (1.0%)
Chronic Nausea 926 (1.5%) 477 (1.4%) 419 (1.8%)
Fibromyalgia 726 (1.2%) 70 (0.2%) 597 (2.6%)
Headaches 707 (1.2%) 356 (1.1%) 307 (1.3%)
Epilepsy 626 (1.0%) 372 (1.1%) 224 (1.0%)
Other 6519 (10.6%) 3443 (10.2%) 2433 (10.5%)
  1. Table 5 presents a summary of the individuals reporting each primary condition overall and by gender. Patients could only report one primary condition. Any condition representing less than 1.0% was grouped as an “other”. A list of “other” primary conditions is available in Table 8. Percentages are calculated from the sample size for each respective column. ADD attention deficit disorder, ADHD attention deficit hyperactivity disorder